Greg Beattie

Greg Beattie has extensive work experience in the biopharmaceutical industry. Greg is currently the Chief Operating Officer at Inotiv, a position they have held since February 2021. Prior to this role, Greg held various leadership positions at Charles River Laboratories, including Corporate Vice President for Biologics Testing Solutions, where they led a major expansion effort and achieved impressive sales and profitability growth. Greg was also responsible for Global Biologics Testing Solutions, overseeing 10 facilities in 5 countries and managing viral clearance services. Greg has a strong background in research operations, with experience in insourcing solutions, preclinical services, and site operations. Before joining Charles River Laboratories, they worked as a Senior Research Scientist in the Toxicology Division at ClinTrials Bioresearch.

Greg Beattie's education history includes the following:

From 2020 to 2021, they attended the Quantic School of Business and Technology, where they pursued a Master of Business Administration (MBA) degree. The specific field of study is not provided.

In 2002 and 2003, they attended the Northwestern University - Kellogg School of Management for the Kellogg Management Institute, an executive education program.

Between 1992 and 1996, they studied at the Université du Québec - Institut national de la recherche scientifique and earned a Master of Science (M.Sc.) degree in Experimental Health Sciences.

From 1986 to 1989, they attended McGill University, where they obtained a Bachelor of Science degree in Biology.

Furthermore, Greg Beattie obtained an additional certification as a Diplomate of the American Board of Toxicology from the American Board of Toxicology, Inc. in October 1999. No other information about the certification is provided.